Johannes Wolff MD PhD

Global Senior Medical Director at AbbVie
Summary
Dr. Johannes Wolff is a distinguished medical professional specializing in global oncology development with a focus on pediatric hematology oncology. With a strong background in clinical practice, research, teaching, and administration, Dr. Wolff has over a decade of valuable experience in renowned institutions like MD Anderson Cancer Center, Tufts Medical Center, and Cleveland Clinic.
After completing his medical training in Germany, Dr. Wolff relocated to the United States where he accumulated a wealth of clinical experience across various prestigious medical centers. He has an impressive publication record of over 200 publications, showcasing his commitment to advancing cancer treatment through research and academia.
In 2015, Dr. Wolff transitioned to the pharmaceutical industry, starting his journey at Novartis before joining AbbVie. His current role as a Senior Medical Director allows him to contribute significantly to the development of new cancer drugs and the strategic utilization of these treatments in combating cancer.
Having studied at esteemed institutions such as the University of Münster, The Johns Hopkins University, and the University of Düsseldorf, Dr. Wolff's educational background is extensive and diverse, covering various aspects of medicine including pediatric hematology oncology, neurobiology, and clinical pediatrics.
Throughout his career, Dr. Wolff has held key positions in reputable organizations, including his current role as Senior Medical Director at AbbVie. His past roles as Chief Medical Officer at NeoGlia, Senior Director at Novartis, and various professorial positions in renowned medical institutions underscore his expertise and leadership in the field of oncology.
Dr. Johannes Wolff's dedication to the fight against cancer is reflected in his active involvement in clinical trials aimed at discovering and implementing innovative cancer treatments. With a comprehensive professional background and a relentless commitment to advancing oncology, Dr. Wolff continues to be a prominent figure in the medical community.